MEDICINA Y CIRUGIA
Departamento
Hospital Morales Meseguer
Murcia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Morales Meseguer (20)
2024
-
Standard and Expanded Series Patch Testing Update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC)
Actas Dermo-Sifiliograficas, Vol. 115, Núm. 7, pp. 712-721
2021
-
European Surveillance System on Contact Allergies (ESSCA): Characteristics of patients patch tested and diagnosed with irritant contact dermatitis
Contact Dermatitis, Vol. 85, Núm. 2, pp. 186-197
2020
-
Efficiency in patch testing: the number needed to test to get one relevant result as a new approach in the evaluation of baseline series
British Journal of Dermatology
-
Is p-Phenylenediamine Still a Prevalent Contact Allergen in Spain?
Actas Dermo-Sifiliograficas, Vol. 111, Núm. 1, pp. 47-52
-
Recommendations of the Working Groups from the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) for the management of adult critically ill patients in the coronavirus disease (COVID-19)
Medicina Intensiva, Vol. 44, Núm. 6, pp. 371-388
-
Trend of relevant contact allergens of the feet in Spain over a period of 10 years
Contact Dermatitis, Vol. 82, Núm. 4, pp. 211-217
2019
-
European Surveillance System on Contact Allergies (ESSCA): Contact allergies in relation to body sites in patients with allergic contact dermatitis
Contact Dermatitis, Vol. 80, Núm. 5, pp. 263-272
-
Is p-Phenylenediamine Still a Prevalent Contact Allergen in Spain?
Actas Dermo-Sifiliograficas
2018
-
Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study
Contact Dermatitis, Vol. 78, Núm. 1, pp. 76-82
2017
-
Contact sensitization to limonene and linalool hydroperoxides in Spain: a GEIDAC* prospective study
Contact Dermatitis, Vol. 76, Núm. 2, pp. 74-80
-
Reconstruction Techniques of Choice for the Facial Cosmetic Units
Actas Dermo-Sifiliograficas, Vol. 108, Núm. 8, pp. 729-737
2016
-
Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome
Critical Care, Vol. 20, Núm. 1
2015
-
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry
Thrombosis Journal, Vol. 13, Núm. 1
2014
2012
-
Corticosteroid therapy in patients with primary viralpneumonia due to pandemic (H1N1) 2009influenza
Journal of Infection, Vol. 64, Núm. 3, pp. 311-318
2011
-
Community-acquired respiratory coinfection in critically III patients with pandemic 2009 influenza A(H1N1) virus
Chest, Vol. 139, Núm. 3, pp. 555-562
-
Impact of obesity in patients infected with 2009 influenza A(H1N1)
Chest, Vol. 139, Núm. 2, pp. 382-386
-
Severe pandemic (H1N1)v influenza A infection: Report on the first deaths in Spain
Respirology, Vol. 16, Núm. 1, pp. 78-85
2009
-
Prevalencia de enfermedad arterial periférica asintomática en pacientes con ictus isquémico no cardioembólico
Neurologia, Vol. 24, Núm. 6, pp. 366-372
2003
-
Factors related to hospital stay among patients with nosocomial infection acquired in the intensive care unit
Infection Control and Hospital Epidemiology, Vol. 24, Núm. 3, pp. 207-213